0

PUGNAc

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP132489691
CAS132489-69-1
Structure
MDL NumberMFCD00145022
Molecular Weight353.33
InChI KeyPBLNJFVQMUMOJY-JXZOILRNSA-N
REAXYS Number4274031
Description≥95% (HPLC)
Assay≥95% (HPLC)
Size5MG, 10MG
Storage Conditions−20°C
1

Dissecting PUGNAc-mediated Inhibition of the Pro-Survival Action of Insulin

Chin Fen Teo, Enas Gad El-Karim, Lance Wells

Glycobiology. 2016 Nov;26(11):1198-1208.

PMID: 27072814

1

O-GlcNAcylated c-Jun Antagonizes Ferroptosis via Inhibiting GSH Synthesis in Liver Cancer

Yan Chen, Guoqing Zhu, Ya Liu, Qi Wu, Xiao Zhang, Zhixuan Bian, Yue Zhang, Qiuhui Pan, Fenyong Sun

Cell Signal. 2019 Nov;63:109384.

PMID: 31394193

1

Prolonged Incubation in PUGNAc Results in Increased Protein O-Linked Glycosylation and Insulin Resistance in Rat Skeletal Muscle

Edward B Arias, Junghoon Kim, Gregory D Cartee

Diabetes. 2004 Apr;53(4):921-30.

PMID: 15047606

1

PUGNAc Treatment Leads to an Unusual Accumulation of Free Oligosaccharides in CHO Cells

Ali Mehdy, Willy Morelle, Claire Rosnoblet, Dominique Legrand, Tony Lefebvre, Sandrine Duvet, François Foulquier

J Biochem. 2012 Apr;151(4):439-46.

PMID: 22337894

1

PUGNAc Treatment Provokes Globotetraosylceramide Accumulation in Human Umbilical Vein Endothelial Cells

Tetsuya Okuda

Biochem Biophys Res Commun. 2017 May 20;487(1):76-82.

PMID: 28392398

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode